The key role of AT1aR in AAA development is underscored by the evidence that AT1aR blockers (ARBs) inhibit AngII-induced AAA development in rodent models34, 35 and that AT1aR polymorphisms are associated with AAA in humans36. Here, AGT is linked to triple-A syndrome.